EOLS – Evolus, Inc.
Float Short %
14.88
Margin Of Safety %
Put/Call OI Ratio
0.38
EPS Next Q Diff
0.06
EPS Last/This Y
0.42
EPS This/Next Y
0.32
Price
4.37
Target Price
14.67
Analyst Recom
1.29
Performance Q
-37.84
Upside
-828.8%
Beta
1.02
Ticker: EOLS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | EOLS | 4.91 | 0.22 | 0.44 | 7159 |
| 2026-01-26 | EOLS | 4.8 | 0.22 | 0.07 | 7221 |
| 2026-01-27 | EOLS | 4.95 | 0.22 | 0.42 | 7464 |
| 2026-01-28 | EOLS | 4.8 | 0.31 | 0.00 | 14133 |
| 2026-01-29 | EOLS | 4.65 | 0.31 | 0.04 | 14199 |
| 2026-01-30 | EOLS | 4.68 | 0.30 | 0.14 | 14404 |
| 2026-02-02 | EOLS | 4.91 | 0.30 | 0.02 | 14389 |
| 2026-02-03 | EOLS | 4.7 | 0.30 | 0.03 | 14358 |
| 2026-02-04 | EOLS | 4.6 | 0.31 | 0.21 | 14342 |
| 2026-02-05 | EOLS | 4.41 | 0.31 | 0.60 | 14414 |
| 2026-02-06 | EOLS | 4.49 | 0.31 | 0.00 | 14438 |
| 2026-02-09 | EOLS | 4.24 | 0.33 | 2.19 | 13501 |
| 2026-02-10 | EOLS | 4.45 | 0.38 | 0.00 | 13875 |
| 2026-02-11 | EOLS | 4.3 | 0.38 | 2.00 | 13910 |
| 2026-02-12 | EOLS | 4.28 | 0.38 | 0.19 | 14021 |
| 2026-02-13 | EOLS | 4.3 | 0.38 | 9.19 | 14022 |
| 2026-02-17 | EOLS | 4.39 | 0.39 | 0.00 | 14165 |
| 2026-02-18 | EOLS | 4.34 | 0.39 | 1.17 | 14259 |
| 2026-02-19 | EOLS | 4.42 | 0.38 | 0.17 | 14192 |
| 2026-02-20 | EOLS | 4.36 | 0.38 | 999.99 | 14329 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | EOLS | 4.91 | 313.7 | 36.6 | -0.39 |
| 2026-01-26 | EOLS | 4.80 | 313.7 | 36.6 | -0.39 |
| 2026-01-27 | EOLS | 4.94 | 313.7 | 36.5 | -0.39 |
| 2026-01-28 | EOLS | 4.80 | 313.7 | 36.6 | -0.39 |
| 2026-01-29 | EOLS | 4.64 | 313.7 | 36.6 | -0.39 |
| 2026-01-30 | EOLS | 4.69 | 313.7 | 36.5 | -0.39 |
| 2026-02-02 | EOLS | 4.91 | 313.7 | 36.5 | -0.39 |
| 2026-02-03 | EOLS | 4.70 | 313.7 | 36.6 | -0.39 |
| 2026-02-04 | EOLS | 4.60 | 313.7 | 36.6 | -0.39 |
| 2026-02-05 | EOLS | 4.42 | 313.7 | 14.2 | -0.39 |
| 2026-02-06 | EOLS | 4.49 | 313.7 | 13.3 | -0.39 |
| 2026-02-09 | EOLS | 4.24 | 151.8 | 14.5 | -0.39 |
| 2026-02-10 | EOLS | 4.45 | 151.8 | 12.8 | -0.39 |
| 2026-02-11 | EOLS | 4.30 | 151.8 | 14.2 | -0.39 |
| 2026-02-12 | EOLS | 4.29 | 151.8 | 13.6 | -0.39 |
| 2026-02-13 | EOLS | 4.29 | 163.8 | 13.5 | -0.39 |
| 2026-02-17 | EOLS | 4.39 | 163.8 | 13.3 | -0.39 |
| 2026-02-18 | EOLS | 4.34 | 163.8 | 13.8 | -0.39 |
| 2026-02-19 | EOLS | 4.42 | 163.8 | - | -0.39 |
| 2026-02-20 | EOLS | 4.37 | 163.8 | - | -0.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | EOLS | 0.08 | -9.96 | 13.66 |
| 2026-01-26 | EOLS | 0.08 | -9.94 | 13.66 |
| 2026-01-27 | EOLS | 0.08 | -9.94 | 13.66 |
| 2026-01-28 | EOLS | 0.08 | -9.94 | 13.83 |
| 2026-01-29 | EOLS | 0.08 | -9.94 | 13.83 |
| 2026-01-30 | EOLS | 0.08 | -9.94 | 13.83 |
| 2026-02-02 | EOLS | 0.08 | -10.11 | 13.83 |
| 2026-02-03 | EOLS | 0.08 | -10.11 | 13.83 |
| 2026-02-04 | EOLS | 0.08 | -10.11 | 13.83 |
| 2026-02-05 | EOLS | 0.08 | -10.11 | 13.83 |
| 2026-02-06 | EOLS | 0.08 | -10.11 | 13.83 |
| 2026-02-09 | EOLS | 0.08 | -10.36 | 13.83 |
| 2026-02-10 | EOLS | 0.08 | -10.36 | 13.83 |
| 2026-02-11 | EOLS | 0.08 | -10.36 | 14.88 |
| 2026-02-12 | EOLS | 0.08 | -10.36 | 14.88 |
| 2026-02-13 | EOLS | 0.08 | -10.36 | 14.88 |
| 2026-02-17 | EOLS | 0.08 | 2.25 | 14.88 |
| 2026-02-18 | EOLS | 0.08 | 2.25 | 14.88 |
| 2026-02-19 | EOLS | -0.12 | 2.25 | 14.88 |
| 2026-02-20 | EOLS | -0.12 | 2.25 | 14.88 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.2
Avg. EPS Est. Current Quarter
0.06
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
-0.12
Institutional Transactions
2.25
Beta
1.02
Average Sales Estimate Current Quarter
90
Average Sales Estimate Next Quarter
73
Fair Value
Quality Score
31
Growth Score
48
Sentiment Score
20
Actual DrawDown %
75.5
Max Drawdown 5-Year %
-75.8
Target Price
14.67
P/E
Forward P/E
PEG
P/S
0.99
P/B
P/Free Cash Flow
EPS
-0.91
Average EPS Est. Cur. Y
-0.39
EPS Next Y. (Est.)
-0.06
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.49
Relative Volume
0.38
Return on Equity vs Sector %
174.6
Return on Equity vs Industry %
196.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 329
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading